NMO Archives - Mayo Clinic News Network

Trending/NMO

By Susan Barber Lindquist
May 3, 2019
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

Study shows drug reduces risk of relapse with neuromyelitis optica

ROCHESTER, Minn. — The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder…

By Gina Chiri-Osmond
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

November 6, 2018

Mayo researchers correlate specific antibody with relapse of neurological disorder

By Dana Sparks
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

January 28, 2018

Sharing Mayo Clinic: Second opinion shifts aspiring filmmaker’s outlook

By Dana Sparks
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

October 8, 2012

New Therapy for Neuromyelitis Optica Symptoms

Special Topics

Sign up

For Journalists Only Sign up for a Media Pass

Mayo Clinic Connect

An online patient support community

Trending/NMO

Study shows drug reduces risk of relapse with neuromyelitis optica

Special Topics

Cancer

Cardiovascular

Gastroenterology

Neurosciences

Transplant

Research

Mayo Clinic Minute

Healthy Living

Sports Medicine

Children's Center

Sign up